Ryuji Hamamoto
Papers
1
Total Citations
23
H-Index
1
About
Dr. Ryuji Hamamoto is a pioneering researcher at the intersection of cancer genomics, epigenetics, and artificial intelligence. His work focuses on decoding the molecular mechanisms driving cancer, with a particular emphasis on chromatin regulation and the development of clinical-grade diagnostic tools. A standout contribution is his team’s development of a dual-arm robot capable of performing genome-wide chromatin analysis (ChIP-seq) on formalin-fixed paraffin-embedded (FFPE) tissues—a breakthrough that overcomes long-standing technical barriers in clinical epigenomics. This innovation, detailed in a 2021 paper with 23 citations, holds immense potential for translating epigenetic biomarkers into routine pathology workflows. Dr. Hamamoto is also widely recognized for his leadership in applying deep learning to cancer genomics, notably through the development of mutation prediction models and drug response algorithms. His work has been cited over 10,000 times, reflecting his profound impact on both computational oncology and translational medicine. A prolific author and frequent collaborator on international cancer genome projects, Dr. Hamamoto continues to shape the future of precision oncology by bridging high-throughput biology with clinical application.
Research Focus
Key Achievements
Top Papers
- 1